NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?
Jongmin HwangSeongwook HanHan-Joon BaeSeung-Woon JunSang-Woong ChoiCheol-Hyun LeeIn-Cheol KimYun-Kyeong ChoHyoung-Seob ParkHyuck-Jun YoonHyungseop KimChang-Wook NamSeung-Ho HurSang-Hoon LeePublished in: Thrombosis and haemostasis (2019)
Most patients who were taking NOACs had excellent adherence regardless of the dosing frequency. An MMAS ≥ 3 could be used as a simple screening tool for a poor NOAC adherence.